|
DOSAGE
|
Seasonal Allergic Conjunctivitis: 1 gtt BID for ocular itching
|
|
Post-Op Inflammation (Cataract): 1 gtt BID in operated eye (start 24 hrs PRIOR to surgery), day of surgery and then continue for 2 weeks
|
|
GENERIC
|
ketorolac tromethamin 0.45%
|
|
SIZE
|
Box of 30 x 0.4mL single-use vial
|
|
INDICATIONS
|
ACUVAIL® ophthalmic solution is indicated for the treatment of pain and inflammation following cataract surgery.
|
|
MECHANISM OF ACTION
|
NSAID (Non-selective COX inhibitor): Inhibits prostaglandin synthesis.
|
|
MICROBIOLOGY
|
Ketorolac tromethamine is a nonsteroidal anti-inflammatory drug which, when administered systemically, has demonstrated analgesic, anti-inflammatory, and anti-pyretic activity. The mechanism of its action is thought to be due to its ability to inhibit prostaglandin biosynthesis.
|
|
CONTRAINDICATIONS & WARNINGS
|
Delayed Healing, Epithelial breakdown, corneal thinning, corneal erosion, corneal ulceration or corneal perforation possible in susceptible patients.
|
|
Hypersensitivity to any of the ingredients in the formulation. Possible cross-sensitivity to acetylsalicylic acid, phenylacetic acid derivatives, and other nonsteroidal anti-inflammatory agents.
|
|
PEDIATRIC USE
|
Safety and effectiveness in pediatric patients have not been established.
|
|
PREGNANCY
|
Category C Teratogenic Effects: There are no adequate and well-controlled studies in pregnant women. ACUVAIL solution should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.
|
|
NOTE
|
BAK and edetate free. Carboxymethylcellulose increases comfort and extends contact period.
|
